Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer

Circulating cell-free DNA (cfDNA), which can be obtained from plasma or serum by non-invasive procedures, has showed great potential to predict treatment response and survival for cancer patients. Several studies have assessed the prognostic and predictive value of cfDNA in non-small cell lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Bo, Liu, Huiquan, Huang, Yu, Peng, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190120/
https://www.ncbi.nlm.nih.gov/pubmed/27323821
http://dx.doi.org/10.18632/oncotarget.10069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190120/
https://www.ncbi.nlm.nih.gov/pubmed/27323821
http://dx.doi.org/10.18632/oncotarget.10069

Ejemplares similares